Filing Details
- Accession Number:
- 0001610717-24-000467
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-06 16:56:08
- Reporting Period:
- 2024-09-04
- Accepted Time:
- 2024-09-06 16:56:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711404 | Cooper Companies Inc. | COO | Ophthalmic Goods (3851) | 942657368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1368867 | G Daniel Mcbride | C/O The Cooper Companies, Inc. 6101 Bollinger Canyon Road, Suite 500 San Ramon CA 94583 | Evp & Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-04 | 114,992 | $43.83 | 159,688 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-04 | 87,537 | $105.21 | 72,151 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-04 | 26,555 | $106.33 | 45,596 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-04 | 900 | $107.00 | 44,696 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-09-04 | 114,992 | $0.00 | 114,992 | $43.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-12-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 94,496 | Indirect | The McBride Family Trust |
Footnotes
- Adjusted to reflect Issuer's 4-for-1 stock split effected on February 16, 2024.
- Includes 42 shares, 182 shares and 52 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on February 1, 2024, May 1, 2024 and August 1, 2024, respectively.
- Includes 8,480 shares previously reported as indirect holdings.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.99. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.005 to $106.95. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.975 to $107.06. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
